DRUG FOR SIMULTANEOUSLY REDUCING RISK OF HAEMORRHAGE AND MICROVASCULAR OBSTRUCTION

摘要

Provided in the present invention is a drug for simultaneously reducing the risk of haemorrhage and microvascular obstruction. Specifically, the present invention provides a composition, the composition comprising (a) a therapeutically effective dose of a first active ingredient, the first active ingredient being clopidogrel or a pharmaceutically acceptable salt thereof; (b) a therapeutically effective dose of a second active ingredient, the second active ingredient being salvianolic acid B or a pharmaceutically acceptable salt thereof; and (c) a therapeutically effective dose of a third active ingredient, the third active ingredient being ginsenoside Rg1 or a pharmaceutically acceptable salt thereof. The first active ingredient, the second active ingredient, and the third active ingredient of the present invention can produce a bilateral synergistic protective effect, effectively reducing microvascular obstruction and effectively preventing haemorrhage, and reducing the dosage of single drugs and reducing drug toxicity.